To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.
We are pleased to provide you with information on products and services that might be of interest to you.
 
EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:

•  Compare criteria for choosing onabotulinumtoxinA or
   neuromodulation treatment for individual patients with
   refractory OAB

•  Perform procedural techniques for use of intradetrusor injections
   of onabotulinumtoxinA and office-based neuromodulation for
   refractory OAB
 
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedEdicus LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION
Global Education Group designates this CME activity for a maximum of 1.75 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

This activity is jointly provided by Global Education Group and MedEdicus LLC.

This activity is supported by an educational grant from Allergan, Inc. and Uroplasty.
 

©2015 MedEdicus LLC
MedEdicus LLC, 73 Redding Road, Georgetown CT 06829-0839
If you do not wish to receive email from MedEdicus in the future regarding CME programs, please click here.